tirzepatide trial results (Zepbound; Eli Lilly and Co) demonstrated 47% greater relative weight loss compared to semaglutide (Wegovy; Novo Nordisk) in the SURMOUNT-5 phase 3b open-label trial. Full will be presented at a Overview of the SURPASS clinical

GLP-1 Is a Tool, Not a Shortcut Its important to understand that GLP-1 medications are not a replacement for healthy habits

3094) was created in February 2024 and is about gastrointestinal complications (e.g., ileus, pancreatitis, and gastroparesis) that the drug allegedly caused

Adipocyte nuclei were identified based on the expression of established markers ( Lipe , Plin4 , Plin1 and Pparg ) and filtered for reclustering using Seurat

This range optimizes the balance between mechanical tension (which preserves muscle) and metabolic stress (which supports fat loss)

Every plan is different, and the optimal outcome comes from consulting with a seasoned cosmetic surgeon

In this post, well share some points to help you have the conversation if you decide to